Cargando…
Optimizing the implementation of future treatment using surrogate end-points
Autor principal: | Dowsett, Mitch |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2614852/ https://www.ncbi.nlm.nih.gov/pubmed/19128440 http://dx.doi.org/10.1186/bcr2186 |
Ejemplares similares
-
Use of Surrogate end points in HTA
por: Mangiapane, Sandra, et al.
Publicado: (2009) -
Surrogates are just surrogates, but helpful just the same
por: Fabian, Carol
Publicado: (2007) -
Short-term presurgical treatment for all?
por: Dowsett, Mitch, et al.
Publicado: (2007) -
Clinical outcomes: to be a surrogate or not to be ...?
por: Cameron, David
Publicado: (2007) -
Surrogate end points and their role in clinical trial
por: Jaykaran,
Publicado: (2009)